Abstract
Metagenomic next-generation sequencing (mNGS) has emerged as a potentially powerful tool in clinical diagnosis, hospital epidemiology, microbial evolutionary biology, and studies of host-pathogen interaction. The SARS-CoV-2 pandemic provides a framework for demonstrating the applications of this technology in each of these areas. In this Supplement, we review applications of mNGS within the discipline of pediatric infectious diseases.
| Original language | English |
|---|---|
| Pages (from-to) | S69-S70 |
| Journal | Journal of the Pediatric Infectious Diseases Society |
| Volume | 10 |
| DOIs | |
| State | Published - Dec 1 2021 |
Keywords
- SARS-CoV-2
- diagnostics
- infectious diseases
- metagenomic next-generation sequencing
- pediatrics
Fingerprint
Dive into the research topics of 'Metagenomic Next-Generation Sequencing (mNGS): SARS-CoV-2 as an Example of the Technology’s Potential Pediatric Infectious Disease Applications'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver